載入...

Expanding Patient Access to Investigational Drugs: Single Patient Investigational New Drug and the “Right to Try”

With drug approval times taking an average of 8 years from entry into clinical trials to full U.S. Food and Drug Administration (FDA) approval, patients with life-threatening and severely debilitating disease and no reasonable therapeutic options are advocating for expanded access (EA) to investigat...

全面介紹

Na minha lista:
書目詳細資料
發表在:JACC Basic Transl Sci
主要作者: Van Norman, Gail A.
格式: Artigo
語言:Inglês
出版: Elsevier 2018
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6059004/
https://ncbi.nlm.nih.gov/pubmed/30062214
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jacbts.2017.11.007
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!